Uropathy Treatment Market Size | Trends Report, 2024 – 2032

Uropathy Treatment Market - By Treatment Type (Medication [Antibiotics, Alpha-blockers], Drainage Devices [Catheter, Ureteral Stents], Surgical Procedure), Age Group (Below 20, 21 – 40, 41 – 60, 61 - 80), End-user – Global Forecast (2024 – 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increasing prevalence of urological disorders

3.2.1.2&nbsp;&nbsp;&nbsp;Growing preference for minimally invasive procedures

3.2.1.3&nbsp;&nbsp;&nbsp;Technological advancements in catheters and stents

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Risk of infection and discomfort due to stents and catheters

3.3&nbsp;&nbsp;&nbsp; Regulatory landscape

3.4&nbsp;&nbsp;&nbsp; Pipeline analysis

3.5&nbsp;&nbsp;&nbsp; Future market trends

3.6&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Treatment Type, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Medication

5.2.1&nbsp;&nbsp;&nbsp; Antibiotics

5.2.2&nbsp;&nbsp;&nbsp; Alpha-blockers or alpha-reductase inhibitors

5.2.3&nbsp;&nbsp;&nbsp; Other medication

5.3&nbsp;&nbsp;&nbsp; Drainage devices

5.3.1&nbsp;&nbsp;&nbsp; Catheters

5.3.1.1&nbsp;&nbsp;&nbsp;Indwelling catheters

5.3.1.2&nbsp;&nbsp;&nbsp;Intermittent catheter

5.3.1.3&nbsp;&nbsp;&nbsp;Suprapubic catheter

5.3.2&nbsp;&nbsp;&nbsp; Ureteral stents

5.4&nbsp;&nbsp;&nbsp; Surgical procedure

5.5&nbsp;&nbsp;&nbsp; Other treatment types

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Age Group, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Below 20

6.3&nbsp;&nbsp;&nbsp; 21 - 40

6.4&nbsp;&nbsp;&nbsp; 41 - 60

6.5&nbsp;&nbsp;&nbsp; 61 - 80

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-User, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Ambulatory surgical centers

7.4&nbsp;&nbsp;&nbsp; Specialty clinics

7.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; The Netherlands

8.3.7&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; Japan

8.4.2&nbsp;&nbsp;&nbsp; China

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.2&nbsp;&nbsp;&nbsp; South Africa

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Astellas Pharma Inc.

9.2&nbsp;&nbsp;&nbsp; B. Braun Melsungen AG

9.3&nbsp;&nbsp;&nbsp; Becton, Dickinson, and Company

9.4&nbsp;&nbsp;&nbsp; Boston Scientific Corporation

9.5&nbsp;&nbsp;&nbsp; Cook Medical

9.6&nbsp;&nbsp;&nbsp; Glaxo SmithKline Pharmaceuticals Ltd.

9.7&nbsp;&nbsp;&nbsp; Inceler Medikal Co. Ltd.

9.8&nbsp;&nbsp;&nbsp; KARL STORZ

9.9&nbsp;&nbsp;&nbsp; Purdue Pharma

9.10&nbsp;&nbsp;&nbsp; Olympus America

9.11&nbsp;&nbsp;&nbsp; Pfizer Inc.

9.12&nbsp;&nbsp;&nbsp; Sun Pharmaceutical Industries Europe B.V.

9.13&nbsp;&nbsp;&nbsp; Synthon BV

9.14&nbsp;&nbsp;&nbsp; Teleflex Incorporated.

9.15&nbsp;&nbsp;&nbsp; UROMED Kurt Drews KG

&nbsp;&nbsp;&nbsp;

Uropathy Treatment Market

Get a free sample of this report